ASCO 2019 – Lenalidomide reduces risk that smoldering myeloma will progress to myeloma in high risk patientsConferences, Myeloma31 May 2019
MPE will hold a webinar on ASH 2018 highlights in myeloma and AL amyloidosisAL amyloidosis, Conferences, MPE, Myeloma16 January 2019
New data presented at ASH 2018 from an ongoing phase I clinical trial of CAR T cell therapy in relapsed/refractory myelomaConferences, Myeloma4 December 2018
Trust in non-conventional therapies by cancer patients not matched with proper awareness about their risksConferences11 October 2018
Denosumab delays the time to first skeletal-related event in patients with myelomaConferences, Myeloma5 June 2017
